Aggressive risk factor modification and pharmacological therapy are the basic steps in managing peripheral arterial disease

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.11, 2006-11, pp. : 17-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Treatment of Patients with Peripheral Arterial Disease

By Kim C.K.   Schmalfuss C.M.   Schofield R.S.   Sheps D.S.  

Drugs, Vol. 63, Iss. 7, 2003-01 ,pp. : 637-647

Adis International

Access to resources Recommend Favorite

Cilostazol and peripheral arterial disease

By Pearce Lyndsay   Ghosh Jonathan   Counsell Andrew   Serracino-Inglott Ferdinand  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2683-2690

Informa Healthcare

Access to resources Recommend Favorite

Hypertension in Peripheral Arterial Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3615-3620

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants in Peripheral Arterial Disease

By  

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 651-655

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs in peripheral arterial disease

By Tulsyan Nirman   Ouriel Kenneth   Kashyap Vikram S  

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 75-90

Informa Healthcare

Access to resources Recommend Favorite